Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Innovus Pharmaceuticals Inc (INNVD)

Innovus Pharmaceuticals Inc (INNVD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Innovus Pharmaceuticals Inc 8845 Rehco Road San Diego CA 92121 USA

www.innovuspharma.com P: 858-964-5123

Description:

Innovus Pharmaceuticals, Inc. is a commercial-stage pharmaceutical company. It delivers non-prescription medicine and consumer care products to improve men's and women's health and vitality. It has a robust portfolio of sexual dysfunction treatments, cough, cold, respiratory disease treatments and pain management medication, as well as skin care products. Its male and female sexual health and vitality products include Zestra (R) to increase desire, arousal, and satisfaction in women; EjectDelay (R) for treating premature ejaculation; Sensum+ (TM) that increases penile sensitivity; Zestra Glide (R); and Vesele (R) to maximize nitric oxide beneficial effects on sexual functions and brain health. Innovus Pharmaceuticals, Inc. is based in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 7,067
Shares Outstanding, K 2,356
Annual Sales, $ 23,990 K
Annual Net Income, $ -8,280 K
Last Quarter Sales, $ 4,750 K
Last Quarter Net Income, $ -2,160 K
60-Month Beta 2.89
% of Insider Shareholders 16.43%
% of Institutional Shareholders 10.38%
Float, K 1,969
% Float 83.57%

Growth:

1-Year Return -81.20%
3-Year Return -81.68%
5-Year Return -92.86%
5-Year Revenue Growth 239,800.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 05/13/19
Earnings Per Share ttm -4.14
EPS Growth vs. Prev Qtr 5.95%
EPS Growth vs. Prev Year 5.95%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-105 on 03/18/19

INNVD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -682.54%
Return-on-Assets % -78.58%
Profit Margin % -34.51%
Debt/Equity 0.00
Price/Sales 0.29
Price/Cash Flow N/A
Price/Book 64.02
Book Value/Share -0.05
Interest Coverage -4.71
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar